Survivors of stroke and transient ischaemic attacks are at risk of a recurrent stroke, which is
often more severe and disabling than the index event. Optimum secondary prevention of …

There is evidence indicating that statins (3-hydroxy-methylglutaryl coenzyme A reductase
inhibitors) may produce several cholesterol-independent antithrombotic effects. In this …

Objectives: This study sought to determine if in addition to standard preventive measures on-
admission, high-dose rosuvastatin exerts a protective effect against contrast-induced acute …

Background Medication adherence is generally low and challenging to address because
patient actions control healthcare delivery outside of medical environments. Behavioral …

Patients with acute coronary syndrome are recommended for early aggressive low-density
lipoprotein (LDL) cholesterol–lowering therapy. The LUNAR study compared the efficacy of …

Background The early period following the onset of acute coronary syndrome (ACS)
represents a critical stage of coronary heart disease, with a high risk of recurrent events and …

Background Patients with coronary heart disease (CHD) and survivors of acute coronary
syndrome (ACS) are at very high risk for adverse cardiovascular events. Lowering low …

Previous studies have demonstrated that benefits of intensive statin therapy compared to
standard statin therapy begin shortly after an acute event and are continued up to 2 years of …

Objective—Clinical trials of statins during myocardial infarction (MI) have differed in their
therapeutic regimes and generated conflicting results. This study evaluated the role of the …

Background The natural history of atherosclerosis might involve coronary plaque
rupture/erosion, thrombus formation and vessel lumen occlusion, clinically recognized as …